| European Case Law Identifier: | ECLI:EP:BA:2003:T083601.20031007 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 07 October 2003 | ||||||||
| Case number: | T 0836/01 | ||||||||
| Application number: | 97119173.9 | ||||||||
| IPC class: | A61K 38/21 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Human interferon-Beta2A for use as a medicament | ||||||||
| Applicant name: | YEDA RESEARCH AND DEVELOPMENT CO. LTD. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Second/further medical use format (yes) Added subject-matter (no) Novelty (yes) Remittal |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010836eu1.html
Date retrieved: 17 May 2021
